Evidence map›Paper›PMID 36205720›Full record

ArticleThe Journal of cell biology2022

Integrin-based adhesion compartmentalizes ALK3 of the BMPRII to control cell adhesion and migration.

Amaris Guevara-Garcia, Laure Fourel, Ingrid Bourrin-Reynard, Adria Sales, Christiane Oddou, Mylène Pezet, Olivier Rossier, Paul Machillot, Line Chaar, Anne-Pascale Bouin and 4 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Amaris Guevara-GarciaInstitute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale U1209, Centre National de La Recherche Scientifique 5309, Université Grenoble Alpes, Grenoble, France.ORCID 0000-0001-6939-0121
Laure FourelInstitute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale U1209, Centre National de La Recherche Scientifique 5309, Université Grenoble Alpes, Grenoble, France.
Ingrid Bourrin-ReynardInstitute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale U1209, Centre National de La Recherche Scientifique 5309, Université Grenoble Alpes, Grenoble, France.
Adria SalesCommissariat à l'Energie Atomique, Institut National de la Santé et de la Recherche Médicale U1292, Centre National de La Recherche Scientifique Equipe Mixte de Recherche Biomimetism and Regenerative Medicine 5000, Université Grenoble Alpes, Grenoble, France.ORCID 0000-0003-3676-4726
Christiane OddouInstitute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale U1209, Centre National de La Recherche Scientifique 5309, Université Grenoble Alpes, Grenoble, France.
Mylène PezetInstitute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale U1209, Centre National de La Recherche Scientifique 5309, Université Grenoble Alpes, Grenoble, France.ORCID 0000-0002-4365-7454
Olivier RossierCentre National de La Recherche Scientifique, Interdisciplinary Institute for Neuroscience, Interdisciplinary Institute for Neurosciences, Unité Mixte de Recherche 5297, Université Bordeaux, Bordeaux, France.ORCID 0000-0002-6932-931X
Paul MachillotCommissariat à l'Energie Atomique, Institut National de la Santé et de la Recherche Médicale U1292, Centre National de La Recherche Scientifique Equipe Mixte de Recherche Biomimetism and Regenerative Medicine 5000, Université Grenoble Alpes, Grenoble, France.
Line ChaarInstitute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale U1209, Centre National de La Recherche Scientifique 5309, Université Grenoble Alpes, Grenoble, France.ORCID 0000-0002-2498-1347
Anne-Pascale BouinInstitute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale U1209, Centre National de La Recherche Scientifique 5309, Université Grenoble Alpes, Grenoble, France.ORCID 0000-0002-9616-6173
Gregory GiannoneCentre National de La Recherche Scientifique, Interdisciplinary Institute for Neuroscience, Interdisciplinary Institute for Neurosciences, Unité Mixte de Recherche 5297, Université Bordeaux, Bordeaux, France.
Olivier Destaing *Institute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale U1209, Centre National de La Recherche Scientifique 5309, Université Grenoble Alpes, Grenoble, France.ORCID 0000-0001-7622-3700
Catherine Picart *Commissariat à l'Energie Atomique, Institut National de la Santé et de la Recherche Médicale U1292, Centre National de La Recherche Scientifique Equipe Mixte de Recherche Biomimetism and Regenerative Medicine 5000, Université Grenoble Alpes, Grenoble, France.
Corinne Albiges-Rizo *Institute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale U1209, Centre National de La Recherche Scientifique 5309, Université Grenoble Alpes, Grenoble, France.ORCID 0000-0002-6333-4150
Inserm · FRInstitut polytechnique de Grenoble · FRInstitut Interdisciplinaire de Neuroscience · FR

Funding

EPA EP-C-13-022European Research Council 259370
6 · The paper itself

Abstract

The spatial organization of cell-surface receptors is fundamental for the coordination of biological responses to physical and biochemical cues of the extracellular matrix. How serine/threonine kinase receptors, ALK3-BMPRII, cooperate with integrins upon BMP2 to drive cell migration is unknown. Whether the dynamics between integrins and BMP receptors intertwine in space and time to guide adhesive processes is yet to be elucidated. We found that BMP2 stimulation controls the spatial organization of BMPRs by segregating ALK3 from BMPRII into β3 integrin-containing focal adhesions. The selective recruitment of ALK3 to focal adhesions requires β3 integrin engagement and ALK3 activation. BMP2 controls the partitioning of immobilized ALK3 within and outside focal adhesions according to single-protein tracking and super-resolution imaging. The spatial control of ALK3 in focal adhesions by optogenetics indicates that ALK3 acts as an adhesive receptor by eliciting cell spreading required for cell migration. ALK3 segregation from BMPRII in integrin-based adhesions is a key aspect of the spatio-temporal control of BMPR signaling.

Indexed as

Bone Morphogenetic Protein Receptors, Type IBone Morphogenetic Protein Receptors, Type IIIntegrin beta3Bone Morphogenetic Protein 2Cell AdhesionFocal Adhesion Protein-Tyrosine KinasesFocal AdhesionsProtein Serine-Threonine KinasesBone Morphogenetic Protein 2Bone Morphogenetic Protein Receptors, Type IBone Morphogenetic Protein Receptors, Type IIFocal Adhesion Protein-Tyrosine KinasesIntegrin beta3Protein Serine-Threonine Kinases

Identifiers

PMID36205720
PMCPMC9552562
OpenAlexW4303513983

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.